TOP GUN

[BooDog]

Here's one with a little added risk. I played this one last year then took it off my list, made good $$ on it though.

Here's my thinking. The risk side is weakness fundamentally with their failures and add the delisting notice to that.

"The ACORN study failed to demonstrate efficacy over placebo on both primary and secondary endpoints. Owing to this, the company decided to discontinue the development of imsidolimab for the acne indication."
https://finance.yahoo.com/news/anaptysbios-anab-acne-study-imsidolimab-153503593.html

The unknown side is how the new CEO will try and make things happen to avoid the delisting. The CEO has his inducement grant so making it look even better imo would be his goal.

The catalyst side is data. Think we'll see news on their MASTERS study soon. Couple weeks to end of April? I haven't looked at ATHX in some time so really am just restarting my DD.

$ATHX .5949

Early radar setting up for a pinch. Still has a bit to set up so anything now would need a fairly tight stop loss. A gamble position if you would.

ATHX daily


All my opinion.